Teratogenic effect of diphenylhydantoin and/or pluphenazine in mice

Journal of Applied Toxicology

Volumn 16, Issue 3, 1996, Pages 221-225

  Abdel Hamid, Hemmat A ^a   Abdel Rahman, Mohamed S ^a   Abdel Rahman, Sawsan A ^b  

^a RUTGERS NEW JERSEY MEDICAL SCHOOL   (United States)

^b AIN SHAMS UNIVERSITY   (Egypt)

Author keywords

Diphenylhydantoin; Fluphenazine; Mouse fetus; Teratogenicity

Indexed keywords

FLUPHENAZINE; PHENYTOIN;

ANIMAL EXPERIMENT; ANIMAL MODEL; BONE MALFORMATION; BRAIN VENTRICLE; CONFERENCE PAPER; CONTROLLED STUDY; EMBRYO; FEMALE; FETUS; FETUS WEIGHT; INTRAGASTRIC DRUG ADMINISTRATION; MOUSE; NONHUMAN; PRIORITY JOURNAL; SKELETON MALFORMATION; TERATOGENICITY;

ANIMALS; BONE AND BONES; EMBRYONIC AND FETAL DEVELOPMENT; FEMALE; FLUPHENAZINE; MICE; MUTAGENICITY TESTS; PHENYTOIN; PREGNANCY; TERATOGENS;

ANIMALIA;

EID: 0029946323     PISSN: 0260437X     EISSN: None     Source Type: Journal    
DOI: 10.1002/(SICI)1099-1263(199605)16:3<221::AID-JAT336>3.0.CO;2-Q     Document Type: Conference Paper

References (22)

1. K. L. Jones, R. V. Larco, K. A. Johnson and J. Adams, Pattern of malformations in the children of women treated with carbamazepine during pregnancy. N. Engl. J. Med. 320, 1661-1666 (1989).
2. W. Squier, P. L. Hope and R. H. Lindenbaum, Neocerebellar hypoplasia in a neonate following intrauterine exposure to anticonvulsants. Dev. Med. Child Neurol. 32, 725-742 (1990).
3. B. L. Mirkin, Diphenylhydantoin: placental transport, fetal localisation, neonatal metabolism and possible teratogenic effects Pediatr. Pharmacol. Ther. 78, 329-337 (1971).
4. J. W. Hanson and D. W. Smith, The fetal hydantoin syndrome. J. Pediatr. 87, 285-290 (1975).
5. L. E. Bartoshesky, I. Bhan, K. Nagpaul and H. Pashayan, Severe cardiac and ophthalmologic malformations in an infant exposed to diphenylhydantoin in utero. Pediatrics 69, 202-203 (1982).
6. A. Nanda, S. Kaur, O. N. Bhakoo, M. M. Kapoor and A. J. Kanwar, Fetal hydantoin syndrome: a case report. Pediatr. Dermatol. 6, 130-133 (1989).
7. K. M. Massey, Teratogenic effects of diphenylhydantoin sodium. J. Oral. Ther. Pharmacol. 2, 380-385 (1966).
8. R. D. Harbison and B. A. Becker, Relation of dosage and time of administration of diphenylhydantoin to its teratogenic effect in mice. Teratology 2, 305-312 (1969).
9. R. D. Harbison and B. A. Becker, Diphenylhydantoin teratogenicity in rats. Toxicol. Appl. Pharmacol. 22, 193-200 (1972).
10. D. Slone, V. Siskind, O. P. Heinonen, R. R. Monson, D. W. Kaufman and S. Shapiro, Antenatal exposure to the phenothiazines in relation to congenital malformations, perinatal mortality rate, birth weight, and intelligence quotient score. Am. J. Obstet. Gynecol. 128, 486-488 (1977).
11. C. Rumeau-Rouquette, J. Goujard and G. Huel, Possible teratogenic effect of phenothiazines in human beings. Teratology 15, 57-64 (1977).
12. J. T. King, M. C. Barry and E. R. Neary, Perinatal findings in women treated during pregnancy with oral fluphenazine. J. New Drugs 3, 21-25 (1963).
13. K. T. Szabo and R. L. Brent, Species differences in experimental teratogenesis by tranquilising agents. Lancet 30, 565 (1974).
14. C. D. Branes, and L. G. Eltherington, Drug Dosage in Laboratory Animals: a Handbook, p. 185. University of California Press, Berkeley and Los Angeles (1966).
15. J. G. Wilson, Methods for administering agents and detecting malformations in experimental animals. In Teratology: Principles and Techniques, ed. by J. G. Wilson and J. Warkany, pp. 262-277. University of Chicago Press, Chicago (1965).
16. H. Fritz and R. Hess, Ossification of the rat and mouse skeleton in the perinatal period. Teratology 3, 331-338 (1970).
17. F. M. Sullivan and P. R. McElhatton, A comparison of the teratogenic activity of the antiepileptic drugs, carbamazepine, clonazepam, ethosuximide, phenobarbital, phenytoin and primidone in mice. Toxicol. Appl. Pharmacol. 40, 365-378 (1977).
18. J. E. Gibson and B. A. Becker, Teratogenic effects of diphenylhydantoin in Swiss-Webster and A/J mice. Proc. Soc. Exp. Biol. Med. 128, 905-909 (1968).
19. R. P. Miller and B. A. Becker, Teratogenicity of oral diazepam and diphenylhydantoin in mice. Toxicol. Appl. Pharmacol. 32, 53-61 (1975).
20. N. Gerber and K. Arnold, Studies on the metabolism of diphenylhydantoin in mice. J. Pharmacol. Exp. Ther. 167, 77-90 (1969).
21. F. M. Sullivan and P. R. McElhatton, Teratogenic activity of the antiepileptic drugs, phenobarbital, phenytoin and primidone in mice. Toxicol. Appl. Pharmacol. 34, 271-282 (1975).
22. J. R. Beall, A teratogenic study of chlorpromazine, orphenadrine, perphenazine and LSD-25 in rats. Toxicol. Appl. Pharmacol. 21, 230-236 (1972).